Medical Condition News

RSS

New neuroprotective agent for stroke patients potentially found

Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.

8 Oct 2012

Run for Healthy Heart attracts over 2,000 participants

In association with the Billion Hearts Beating Foundation, Indraprastha Apollo Hospitals organised a 5-km run titled 'Dil ki Daud'. In the wee hours of Sunday, more than 2,000 people participated in the 5-km run, which kicked off at 6:45 am. India's first blade runner and Kargil War amputee hero Retd. Major Devender Pal Singh - also participated in order to encourage the runners for a healthy living.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announces the launch of AccuSom Safe Recovery.

8 Oct 2012

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract and a Phase 2 option from the National Cancer Institute (NCI) valued up to $1,683,503.

8 Oct 2012

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it has successfully completed a Phase 2a study on the hemodynamic effects of TRV027 in patients with advanced heart failure with reduced ejection fraction.

8 Oct 2012

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

Hygieia, Inc. today announced that the company's d-Nav Diabetes Insulin Guidance System (DIGS) has been granted a CE mark.

8 Oct 2012

Scientists discover process by which vitamin B12 is made in cells

In a development that may lead to new drugs to treat cancer, scientists at the University of Kent have discovered the process by which a key vitamin (B12) is made in cells.

8 Oct 2012

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

Rainbow Coral Corp. biotech subsidiary Rainbow BioSciences and Amarantus Biosciences have moved into the final stages of the terms for a deal. The pending joint venture agreement will see the two entities working together to move the Amarantus NuroPro Parkinson's diagnostic platform towards commercialization.

8 Oct 2012

USPTO grants five-year extension to Spectrum's FOLOTYN patent

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).

8 Oct 2012

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

GTx, Inc. announced today there will be two scientific poster presentations on the effects of enobosarm, a selective androgen receptor modulator (SARM), on improving physical function and quality of life in middle aged and elderly cancer patients.

8 Oct 2012

New device may restore voice in patients with laryngeal cancer

Patients who have lost their voice box through disease such as throat cancer may be able to speak immediately after a procedure to create a small opening at the throat.

8 Oct 2012

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) doubles the response rate and improves time-to-progression and survival in patients with advanced lung cancer, according to a Phase II clinical trial conducted by investigators at Rational Therapeutics and the MemorialCare Todd Cancer Institute and published in the October issue of Anticancer Research.

8 Oct 2012

Kaiser Permanente to improve food offerings in 37 hospitals

Kaiser Permanente, a champion of healthy eating, announced Saturday it has signed a commitment with the Partnership for a Healthier America to improve food offerings in its 37 hospitals.

8 Oct 2012

Study provides direct evidence for persistent activity in medial entorhinal cortex layer neurons

UCLA researchers have for the first time measured the activity of a brain region known to be involved in learning, memory and Alzheimer's disease during sleep. They discovered that this part of the brain behaves as if it's remembering something, even under anesthesia, a finding that counters conventional theories about memory consolidation during sleep.

8 Oct 2012

NFKB1 gene variant may reduce risk of lung cancer

A variant in a gene involved with inflammation and the immune response is linked with a decreased risk of lung cancer. That is the finding of an analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The results add to the growing body of literature implicating these processes in the development of lung cancer.

8 Oct 2012

Parametric response mapping could improve diagnosis and treatment of COPD

A new approach to lung scanning could improve the diagnosis and treatment of a lung disease that affects approximately 24 million Americans and is the country's third-highest cause of death.

8 Oct 2012

Researchers discover 8 new loci associated with susceptibility to atopic dermatitis

Researchers at the RIKEN Center for Genomic Medicine (CGM) and their colleagues have identified 8 new loci associated with susceptibility to atopic dermatitis in the Japanese population.

8 Oct 2012

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.

8 Oct 2012

Progenra’s USP7 and USP47 exert non-overlapping anticancer cell effects

Researchers at Progenra, Inc. announce the advanced online publication of the article "Selective Dual Inhibitors of the Cancer-related Deubiquitylating Proteases USP7 and USP47." The new article presents evidence of a therapeutic benefit resulting from dual inhibition of USP7 and a related enzyme, USP47.

8 Oct 2012

Medical Condition News

New neuroprotective agent for stroke patients potentially found

Run for Healthy Heart attracts over 2,000 participants

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

Scientists discover process by which vitamin B12 is made in cells

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

USPTO grants five-year extension to Spectrum's FOLOTYN patent

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

New device may restore voice in patients with laryngeal cancer

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Kaiser Permanente to improve food offerings in 37 hospitals

Study provides direct evidence for persistent activity in medial entorhinal cortex layer neurons

NFKB1 gene variant may reduce risk of lung cancer

Parametric response mapping could improve diagnosis and treatment of COPD

Researchers discover 8 new loci associated with susceptibility to atopic dermatitis

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Progenra’s USP7 and USP47 exert non-overlapping anticancer cell effects

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News